Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
In the latest session, Sotera Health Co (NASDAQ: SHC) closed at $16.6 down -0.90% from its previous closing price of $16.75. In other words, the price has decreased by -$0.90 from its previous closing price. On the day, 4.67 million shares were traded. SHC stock price reached its highest trading level at $16.705 during the session, while it also had its lowest trading level at $16.41.
Ratios:
For a deeper understanding of Sotera Health Co’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 15.67 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 41.10. For the most recent quarter (mrq), Quick Ratio is recorded 2.16 and its Current Ratio is at 2.38. In the meantime, Its Debt-to-Equity ratio is 4.14 whereas as Long-Term Debt/Eq ratio is at 4.10.
Upgrades & Downgrades
In the most recent recommendation for this company, BMO Capital Markets on November 13, 2025, initiated with a Outperform rating and assigned the stock a target price of $19.
On May 05, 2025, Goldman Upgraded its rating to Buy which previously was Neutral but kept the price unchanged to $17.
On December 06, 2024, Goldman started tracking the stock assigning a Neutral rating and target price of $14.Goldman initiated its Neutral rating on December 06, 2024, with a $14 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Dec 08 ’25 when Michael B. Petras, Jr. bought 750,000 shares for $16.75 per share.
WARBURG PINCUS & CO. sold 9,720,000 shares of SHC for $158,727,600 on Dec 03 ’25. The Director now owns 34,102,952 shares after completing the transaction at $16.33 per share. On Dec 03 ’25, another insider, WARBURG PINCUS & CO., who serves as the Director of the company, sold 9,720,000 shares for $16.33 each. As a result, the insider received 158,727,600 and left with 34,102,952 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SHC now has a Market Capitalization of 4715959296 and an Enterprise Value of 6738671104. As of this moment, Sotera’s Price-to-Earnings (P/E) ratio for their current fiscal year is 86.01, and their Forward P/E ratio for the next fiscal year is 17.59. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 6.09. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.10 while its Price-to-Book (P/B) ratio in mrq is 8.57. Its current Enterprise Value per Revenue stands at 5.858 whereas that against EBITDA is 12.377.
Stock Price History:
The Beta on a monthly basis for SHC is 1.83, which has changed by 0.26893938 over the last 52 weeks, in comparison to a change of 0.13844287 over the same period for the S&P500. Over the past 52 weeks, SHC has reached a high of $17.78, while it has fallen to a 52-week low of $9.53. The 50-Day Moving Average of the stock is 1.87%, while the 200-Day Moving Average is calculated to be 22.01%.
Shares Statistics:
For the past three months, SHC has traded an average of 2.25M shares per day and 2422200 over the past ten days. A total of 284.09M shares are outstanding, with a floating share count of 203.78M. Insiders hold about 28.27% of the company’s shares, while institutions hold 57.51% stake in the company. Shares short for SHC as of 1763078400 were 7742768 with a Short Ratio of 3.44, compared to 1760486400 on 7248497. Therefore, it implies a Short% of Shares Outstanding of 7742768 and a Short% of Float of 5.0200000000000005.
Earnings Estimates
A detailed examination of Sotera Health Co (SHC) is currently in progress, with 8.0 analysts providing valuable insights into its market dynamics.The consensus estimate for the next quarter is $0.17, with high estimates of $0.18 and low estimates of $0.17.
Analysts are recommending an EPS of between $0.84 and $0.83 for the fiscal current year, implying an average EPS of $0.84. EPS for the following year is $0.94, with 8.0 analysts recommending between $0.97 and $0.92.
Revenue Estimates
A total of 7 analysts believe the company’s revenue will be $299.17M this quarter.It ranges from a high estimate of $299.9M to a low estimate of $298M. As of. The current estimate, Sotera Health Co’s year-ago sales were $290.2MFor the next quarter, 7 analysts are estimating revenue of $269.74M. There is a high estimate of $277.17M for the next quarter, whereas the lowest estimate is $262.36M.
A total of 7 analysts have provided revenue estimates for SHC’s current fiscal year. The highest revenue estimate was $1.16B, while the lowest revenue estimate was $1.16B, resulting in an average revenue estimate of $1.16B. In the same quarter a year ago, actual revenue was $1.1BBased on 7 analysts’ estimates, the company’s revenue will be $1.23B in the next fiscal year. The high estimate is $1.24B and the low estimate is $1.21B.
